Chronic News and Research

RSS

Leading experts propose new treatment guidelines for chronic Lyme disease

Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.

4 Sep 2014

Case Western Reserve scientists discover leaky gut as source of non-AIDS complications

Human immunodeficiency virus (HIV) infection is no longer a fatal condition, thanks to newer medications inhibiting the retrovirus, but a puzzling phenomenon has surfaced among these patients — non-AIDS complications. Scientists at Case Western Reserve University School of Medicine have resolved the mystery with their discovery of the leaky gut as the offender.

4 Sep 2014

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced successful completion of a Phase 1a clinical study of NVR-1221.

4 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

Doctor receives international patents for therapeutic process to remove excess galectin-3

Isaac Eliaz, MD, MS, LAc has been awarded a USA patent as well as additional international patents for a therapeutic process that allows for the removal of excess galectin-3 from the circulatory system using plasmapheresis.

4 Sep 2014

Study explores role of self-esteem and social adjustment in children and adolescents

In the current issue of Psychotherapy and Psychosomatics a Group of Greek investigators is reporting on a study exploring the role of self-esteem and social adjustment in children and adolescents.

4 Sep 2014

Study investigates white matter damage in chronic stages of traumatic axonal injury

Traumatic Axonal Injury is a form of traumatic brain injury that can have detrimental effects on the integrity of the brain's white matter and lead to cognitive impairments.

4 Sep 2014

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to Washington state for-profit and non-profit organizations to promote translation of health-related technologies from the laboratory to the commercial marketplace.

4 Sep 2014

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Since the introduction of the combination anti-retroviral therapy (cART) in the mid-90s, the life expectancy of HIV patients has significantly improved. As a result, long-term complications are becoming more relevant: almost every second HIV patient is affected by neurocognitive disorders, which can lead to dementia.

4 Sep 2014

Study investigates whether function of intestines attacked in MS

The present study investigates whether the function of the intestines is also attacked in MS. The results, obtained from a disease model of MS in mice, shows inflammation and changes in the barrier function of the intestines early in the course of the disease.

4 Sep 2014

Scientists aim to develop rapid test system for immune dysfunction to treat cystic fibrosis

Cystic fibrosis (CF) is a frequent genetic disease affecting the lung and the gastrointestinal tract. Scientists from the Helmholtz Zentrum München now have shown that many of the adult patients with CF in addition lack a cell surface molecule, which is important for immune defence. The results have been published recently in the 'Journal of Molecular Medicine'.

4 Sep 2014

Nature of chemicals released into water became problem with air quality

Andrea Dietrich and Amanda Sain of Virginia Tech's Via Department of Civil and Environmental Engineering estimated that 50 percent of the population taste threshold for manganese II in water, the simplest ionic manganese oxide, to be more than 1000 times the current EPA allowable level.

4 Sep 2014

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Wet AMD is characterized by abnormal growth of blood vessels in the macula (the area of the eye containing vision-enabling photoreceptors), and is responsible for the vast majority of severe vision loss in the industrialized world.

4 Sep 2014

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Bristol-Myers Squibb today announced the launch of Daklinza▼ (daclatasvir) in the UK, a new medicine for the treatment of adult patients with chronic hepatitis C. Daclatasvir, a treatment that works across multiple hepatitis C genotypes, will allow up to 90% of UK patients the option of a potentially curative oral treatment regimen that does not include interferon, a standard of care commonly associated with sustained flu-like side effects.

4 Sep 2014

Professor receives grant from NIH to test effects of high-intensity functional training

Katie Heinrich, assistant professor of kinesiology at Kansas State University, has been awarded an investigator-initiated grant from the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases for more than $2.52 million.

4 Sep 2014

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Chronic tinnitus is a disabling disorder. A new study published in the current issue of Psychotherapy and Psychosomatics reports on a therapy that is performed over internet.

4 Sep 2014

Accreditation of bariatric surgery centers contributes to improved safety for patients

Patients who underwent weight loss operations in recent years, when most bariatric surgical centers were accredited, had fewer postoperative complications and were 2.3 times less likely to die in the hospital than patients who had bariatric procedures performed before a national movement toward facility accreditation was taking place, according to new study findings.

4 Sep 2014

Neuroscientist discovers new mechanism that can reverse chronic pain

It's in the brain where we perceive the unpleasant sensations of pain, and researchers have long been examining how calcium channels in the brain and peripheral nervous system contribute to the development of chronic pain conditions.

4 Sep 2014

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Researchers at the University of California, San Diego School of Medicine, in partnership with the California Institute for Regenerative Medicine (CIRM) and Celgene Corporation, a New Jersey-based biopharmaceutical company, have launched a phase 1 human clinical trial to assess the safety and efficacy of a novel monoclonal antibody for patients with chronic lymphocytic leukemia (CLL).

4 Sep 2014

Dyspnoea in COPD patients heralds worse outcomes

Breathlessness is a common finding in patients with chronic obstructive pulmonary disease and signals an increased risk of exacerbations, study findings indicate.

3 Sep 2014

Chronic News and Research

Leading experts propose new treatment guidelines for chronic Lyme disease

Case Western Reserve scientists discover leaky gut as source of non-AIDS complications

Novira completes Phase 1a clinical study of NVR-1221 for treatment of HBV infection

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Doctor receives international patents for therapeutic process to remove excess galectin-3

Study explores role of self-esteem and social adjustment in children and adolescents

Study investigates white matter damage in chronic stages of traumatic axonal injury

LSDF announces $750,000 in Proof of Concept grants to promote health-related technologies

Findings may help develop biomarkers to identify HIV patients at risk of dementia

Study investigates whether function of intestines attacked in MS

Scientists aim to develop rapid test system for immune dysfunction to treat cystic fibrosis

Nature of chemicals released into water became problem with air quality

Treating wet AMD with gold nanoparticles: an interview with Jim Taylor, CEO, Oraya Therapeutics

Bristol-Myers Squibb launches Daklinza in the UK for treatment of chronic hepatitis C

Professor receives grant from NIH to test effects of high-intensity functional training

ICBT might be equally effective alternative to conventional CBT in management of chronic tinnitus

Accreditation of bariatric surgery centers contributes to improved safety for patients

Neuroscientist discovers new mechanism that can reverse chronic pain

Clinical trial to assess safety and efficacy of novel monoclonal antibody for CLL patients

Dyspnoea in COPD patients heralds worse outcomes

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News